What is the lowest dose of Lokelma (sodium zirconium cyclosilicate) for a patient on chronic hemodialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lokelma Dosing for Hemodialysis Patients

For patients on chronic hemodialysis, start Lokelma at 5 g once daily on non-dialysis days only. 1

Dosing Algorithm for Dialysis Patients

Initial Dose Selection

  • Standard starting dose: 5 g once daily on non-dialysis days 1
  • Higher starting dose (10 g once daily) may be considered if serum potassium is >6.5 mEq/L 1
  • Never administer on dialysis days 1

Dose Titration

After initiating therapy:

  • Monitor pre-dialysis potassium after the long interdialytic interval (typically after the 2-day gap) 1
  • Reassess potassium one week after starting or after any dose adjustment 1
  • Adjust in 5 g increments based on pre-dialysis potassium values 1
  • Maintenance dose range: 5-15 g once daily on non-dialysis days 1

When to Reduce or Stop

Discontinue or decrease the dose if: 1

  • Pre-dialysis potassium falls below target range after the long interdialytic interval
  • Patient develops clinically significant hypokalemia

Evidence Supporting This Approach

The FDA labeling provides the most authoritative guidance, establishing 5 g as the lowest and recommended starting dose specifically for hemodialysis patients. 1 This differs from non-dialysis patients, who typically start at 10 g three times daily for acute treatment.

The DIALIZE trial, which informed these FDA recommendations, demonstrated that 41.2% of patients achieved target potassium control (4.0-5.0 mmol/L) with this dosing strategy, compared to only 1.0% on placebo. 2 The study used the same dosing algorithm: starting at 5 g on non-dialysis days and titrating up to 15 g as needed. 3

Critical Safety Considerations

Watch for hypokalemia in dialysis patients, particularly during acute illnesses that decrease oral intake or cause diarrhea. 1 These patients have minimal renal potassium excretion and depend entirely on dialysis and binders for potassium removal, making them vulnerable to rapid shifts.

Interdialytic weight gain was not increased with Lokelma in clinical trials, despite each 5 g dose containing approximately 400 mg of sodium. 1, 4 However, monitor for edema, especially in patients prone to fluid overload.

Common Pitfalls to Avoid

  • Never give Lokelma on dialysis days - the drug is removed by dialysis and will be ineffective 1
  • Don't start at 10 g unless potassium is >6.5 mEq/L - the lower 5 g dose is sufficient for most dialysis patients and reduces hypokalemia risk 1
  • Don't use other oral medications within 2 hours of Lokelma administration due to potential binding interactions 1
  • Don't use for emergency hyperkalemia treatment - onset of action is delayed; use traditional emergency measures first 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.